DOW UNIVERSITY OF HEALTH SCIENCES

🇵🇰Pakistan

Country: 🇵🇰Pakistan

Ownership: Private

Established: 1945-01-01

Employees: -

Market Cap: -

Website: http://www.duhs.edu.pk

Clinical Trials

Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism

Phase 1

Conditions: Menstrual Irregularities
Hyperandrogenism

Interventions: Drug: TAB METFORMIN
Drug: TAB PIOGLITAZONE

First Posted Date: 2018-11-29

Last Posted Date: 2018-11-29

Lead Sponsor: Dow University of Health Sciences

Target Recruit Count: 110

Registration Number: NCT03757923

Locations: 🇵🇰
Dow University Hospital OJHA, Karachi, Sindh, Pakistan

Behavior Changing Intervention for Smokeless Tobacco and Betel Quid Use in Adolescents

Not Applicable

Completed

Conditions: Oral Cavity Carcinoma

First Posted Date: 2018-04-04

Last Posted Date: 2019-07-17

Lead Sponsor: Dow University of Health Sciences

Target Recruit Count: 2200

Registration Number: NCT03488095

Locations: 🇵🇰
DOW University of Health Sciences, Karachi, Sind, Pakistan

Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy

Phase 2

Completed

Conditions: Type 2 Diabetes Mellitus
Chronic Periodontitis

Interventions: Procedure: Scaling Root Planing
Drug: Metronidazole
Behavioral: Oral Hygiene Instructions

First Posted Date: 2017-11-17

Last Posted Date: 2020-08-21

Lead Sponsor: Dow University of Health Sciences

Target Recruit Count: 150

Registration Number: NCT03343366

Locations: 🇵🇰
Dow University of Health Sciences, Karachi, Sind, Pakistan

Effect of Routine Deworming on Weight of Children

Not Applicable

Completed

Conditions: Soil Transmitted Helminths

Interventions: Dietary Supplement: Calcium 400 mg + Vitamin D 2.5 mcg
Drug: Albendazole

First Posted Date: 2017-05-16

Last Posted Date: 2017-07-13

Lead Sponsor: Dow University of Health Sciences

Target Recruit Count: 300

Registration Number: NCT03155035

Locations: 🇵🇰
Dow University of Health Sciences, Karachi, Sindh, Pakistan

Grid Laser for Diffuse Diabetic Maculopathy

Completed

Conditions: Diabetic Macular Edema

First Posted Date: 2015-09-22

Last Posted Date: 2015-09-22

Lead Sponsor: Dow University of Health Sciences

Target Recruit Count: 50

Registration Number: NCT02555956

Locations: 🇵🇰
Dow universty Hospital,Dow international Medical college, Karachi, Sindh, Pakistan

Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension

Phase 3

Conditions: Postnatal Hypertension

Interventions: Drug: Labetalol
Drug: Nifedipine

First Posted Date: 2015-04-24

Last Posted Date: 2015-04-24

Lead Sponsor: Dow University of Health Sciences

Target Recruit Count: 98

Registration Number: NCT02426177

Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis

Phase 4

Conditions: Type 2 Diabetes Mellitus
Pulmonary Tuberculosis

Interventions: Dietary Supplement: Vitamin D
Dietary Supplement: Placebo Vit D
Dietary Supplement: Placebo Calcium
Dietary Supplement: Calcium

First Posted Date: 2014-06-23

Last Posted Date: 2014-06-23

Lead Sponsor: Dow University of Health Sciences

Target Recruit Count: 435

Registration Number: NCT02169570

Locations: 🇵🇰
School of Public Health, Dow university of Health Sciences, Karachi, Sindh, Pakistan

Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.

Phase 2

Completed

Conditions: Hydralazine Adverse Reaction
Pre-eclampsia
Pre-eclampsia Superimposed Pre-existing Hypertension
Hypertension, Pregnancy Induced

Interventions: Drug: Labetalol
Drug: Hydralazine

First Posted Date: 2014-01-30

Last Posted Date: 2018-10-26

Lead Sponsor: Dow University of Health Sciences

Target Recruit Count: 190

Registration Number: NCT02050529

Locations: 🇵🇰
Civil Hospital Karachi, Karachi, Sindh, Pakistan

Effective Fluoride Concentration In Toothpaste For Dental Caries Prevention

Not Applicable

Conditions: Dental Caries

Interventions: Other: toothpaste 1 with maximum fluoride concentration
Other: toothpaste 2 with 1000 ppm of fluoride

First Posted Date: 2013-12-19

Last Posted Date: 2014-08-13

Lead Sponsor: Dow University of Health Sciences

Target Recruit Count: 380

Registration Number: NCT02016001

Locations: 🇵🇰
Shaheen Public School, Karachi, Sindh, Pakistan

Metformin Treatment in Gestational Diabetes and Noninsulin Dependent Diabetes in Pregnancy in a Developing Country

Phase 2

Conditions: Gestational Diabetes
Type 2 Diabetes
Pregnancy

Interventions: Drug: Metformin
Drug: Insulin

First Posted Date: 2013-05-16

Last Posted Date: 2013-05-16

Lead Sponsor: Dow University of Health Sciences

Target Recruit Count: 300

Registration Number: NCT01855763

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy